Bit Capital Gmb H Karuna Therapeutics, Inc. Transaction History

Bit Capital Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Feb 12, 2025	SELL	$0.0 - $329.83 $0 - $11.7 Million	-35,461 Closed	0 $0
Q4 2023 Feb 12, 2025	BUY	$161.01 - $317.85 $5.51 Million - $10.9 Million	34,220 Added 2757.45%	35,461 $11.2 Billion
Q2 2023 Feb 12, 2025	BUY	$176.32 - $240.22 $51,309 - $69,904	291 Added 30.63%	1,241 $269 Million
Q1 2023 Feb 12, 2025	BUY	$161.33 - $204.36 $153,263 - $194,142	950 New	950 $173 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.